These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1069564)

  • 21. [Viral etiology of some osteogenic osteosarcomas. Critical review].
    Latarjet R
    Bull Cancer; 1971; 58(2):277-86. PubMed ID: 4335234
    [No Abstract]   [Full Text] [Related]  

  • 22. A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung.
    Benjamin R; Helman L; Meyers P; Reaman G
    Hum Gene Ther; 2001 Aug; 12(12):1591-3. PubMed ID: 11529247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The relationship between the prostaglandin E level in the tumor and the times of the metastasis of primary osteogenic sarcoma].
    Bassalyk LS; Kushlinskiĭ NE; Solov'ev IuN; Siniukov PA; Fedenko AN
    Vopr Onkol; 1989; 35(11):1301-5. PubMed ID: 2609517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfer of in vitro cytotoxicity against osteogenic sarcoma cells.
    Sutherland CM; Krementz ET; Hornung MO; Carter RD; Holmes J
    Surgery; 1976 Jun; 79(6):682-5. PubMed ID: 1064179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor immunology of experimental osteosarcoma.
    Ghanta VK; Hiramoto RN; Weiss AB; Caudill L; Davis DW
    Clin Orthop Relat Res; 1978 Jun; (133):246-60. PubMed ID: 278687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune approaches to treating osteosarcoma.
    Marina N; Gorlick R
    Cancer Biol Ther; 2009 May; 8(10):981-3. PubMed ID: 19395866
    [No Abstract]   [Full Text] [Related]  

  • 27. Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.
    Levin AS; Byers VS; Fudenberg HH; Wybran J; Hackett AJ; Johnston JO; Spitler LE
    J Clin Invest; 1975 Mar; 55(3):487-99. PubMed ID: 1078826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Osteogenic sarcoma in children: clinico-immunological correlations].
    Panteleeva ES; Neprina GS; Vatin OE; Bizer VA; Kurasova VG
    Vopr Onkol; 1990; 36(3):304-8. PubMed ID: 2139527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteogenic sarcoma.
    Moore GE; Gerner RE; Brugarolas A
    Surg Gynecol Obstet; 1973 Mar; 136(3):359-66. PubMed ID: 4510918
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunotherapeutic approaches in pediatric osteosarcoma.
    Cao H; Zhang H; Zou H
    Minerva Pediatr; 2018 Dec; 70(6):635-636. PubMed ID: 28353326
    [No Abstract]   [Full Text] [Related]  

  • 31. Specific inhibition of sarcoma-specific cellular immunity by sera from patients with growing sarcomas.
    Cohen AM; Ketcham AS; Morton DL
    Int J Cancer; 1973 Mar; 11(2):273-9. PubMed ID: 4524527
    [No Abstract]   [Full Text] [Related]  

  • 32. The immunotherapy of canine osteosarcoma: a historical and systematic review.
    Wycislo KL; Fan TM
    J Vet Intern Med; 2015; 29(3):759-69. PubMed ID: 25929293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary renal osteogenic sarcoma 14 years after primary therapy.
    Hallet MB; Weiss MA; Aron BS; Bracken RB
    J Urol; 1984 Oct; 132(4):752-4. PubMed ID: 6590875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disapperance of osteogenic sarcoma after irradiation: immunologic observations.
    Urtasun RC; Connachie PR
    J Can Assoc Radiol; 1976 Jun; 27(2):80-3. PubMed ID: 1066352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression of metastatic osteosarcoma following non-myeloablative stem cell transplantation. A case report.
    Fagioli F; Berger M; Brach del Prever A; Lioji S; Aglietta M; Ferrari S; Picci P; Madon E
    Haematologica; 2003 May; 88(5):ECR16. PubMed ID: 12745285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Review of T-Cell Related Therapy for Osteosarcoma.
    Yoshida K; Okamoto M; Aoki K; Takahashi J; Saito N
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the results of treatment of 38 cases of primary osteogenic sarcoma].
    Witwicki T; Daniluk A; Dulowski W; Deszczyński J
    Nowotwory; 1979; Suppl():123-7. PubMed ID: 295455
    [No Abstract]   [Full Text] [Related]  

  • 38. [Considerations on the treatment of osteogenic sarcomas (apropos of 80 cases)].
    Denoix P; Génin J; Kissous J; Sarrazin D; Schweisguth O; Weiler J
    Chirurgie; 1970; 96(1):63-7. PubMed ID: 5279884
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prognosis of osteogenic sarcoma (author's transl)].
    Kalman E
    Bratisl Lek Listy; 1974 Oct; 62(4):440-5. PubMed ID: 4529177
    [No Abstract]   [Full Text] [Related]  

  • 40. Impaired lymphocyte responsiveness in osteosarcoma.
    Twomey PL; Chretien PB
    J Surg Res; 1975 May; 18(5):551-4. PubMed ID: 1055278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.